Monday, August 31, 2026

Coinbase Stock Went Up By Over 12% So Far On Monday

Coinbase Stock Went Up By Over 12% So Far On Monday

(VIANEWS) - Shares of Coinbase (NASDAQ: COIN) rose by a staggering 12.51% to $80.50 at 11:49 EST on Monday, after two consecutive sessions in a row of losses. NASDAQ is falling 0.02% to $13,785.79, following the last session's upward trend. This seems, as yet, a somewhat down trend exchanging session today.

About Coinbase

Coinbase Global, Inc. provides financial infrastructure and technology for the cryptoeconomy in the United States and internationally. It offers the primary financial account in the cryptoeconomy for consumers; a marketplace with a pool of liquidity for transacting in crypto assets for institutions; and technology and services that enable developers to build crypto-based applications and securely accept crypto assets as payment. The company was founded in 2012 and is based in Wilmington, Delaware.

Earnings Per Share

As for profitability, Coinbase has a trailing twelve months EPS of $-11.5.

Volume

Today's last reported volume for Coinbase is 15254305 which is 1.04% above its average volume of 15096400.

Volatility

Coinbase's last week, last month's, and last quarter's current intraday variation average was 3.80%, 0.53%, and 3.96%.

Coinbase's highest amplitude of average volatility was 4.42% (last week), 4.15% (last month), and 3.96% (last quarter).

More news about Coinbase (COIN).

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI's Trust Gap: Microsoft-Mistral Ecosystem Expansion Meets a Governance Deficit in Agentic Adoption
Microsoft is deepening its AI platform bet through simultaneous moves — expanding its Mistral partnership (Copilot Studio, Foundry, European infrastructure capacity) and deepening enterprise AI governance ties with Manulife — just as independent research (Google Cloud, VentureBeat, Box) shows enterprises racing toward agentic AI adoption (100% planned within two years) while data access and trust in agent decisions lag badly (average 45% data access, only ~half trust agent outputs). The result is a structural mismatch between platform-vendor momentum and enterprise readiness to actually govern and trust the agents being deployed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
Same entity (Morgan Stanley & Co. LLC), same metric (net_income), same fiscal period (Q1 2026), same observation date (2026-03-31), but vastly different values: $5.567 billion vs. $5.57. These cannot coexist for the same time period. Fact B appears to be a data entry error (possible missing decimal placement: 5.57 should likely be 5,567,000,000 or a per-share figure incorrectly entered as total).
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,257 source documents archived
Query this data → isubstrate.com